-
Ultima Anastro de haute qualité aux États-Unis culturisme
Ultima Anastro de haute qualité aux États-Unis culturisme Le culturisme est un sport exigeant qui nécessite un engagement sérieux envers l’entraînement, la nutrition et les suppléments. Pour obtenir les meilleurs…
-
Professor Ming Zhao: Advances in the Use of Immunotherapy in Hepatocellular Carcinoma
Since the advent of immune checkpoint inhibitors (ICI) for the treatment of malignant tumors, the exploration of their use in hepatocellular carcinoma (HCC) has been relentless. In 2017 and 2018, nivolumab and pembrolizumab were respectively granted accelerated approval by the FDA for second-line treatment of HCC following progression on sorafenib. However, both agents failed to…
-
Professor Ming Zhao: Advances in the Use of Immunotherapy in Hepatocellular Carcinoma
Since the advent of immune checkpoint inhibitors (ICI) for the treatment of malignant tumors, the exploration of their use in hepatocellular carcinoma (HCC) has been relentless. In 2017 and 2018, nivolumab and pembrolizumab were respectively granted accelerated approval by the FDA for second-line treatment of HCC following progression on sorafenib. However, both agents failed to…
-
test
test test
-
Beneficios de Universal Animal Flex 44 bolsas curso
Beneficios de Universal Animal Flex 44 bolsas curso Universal Animal Flex 44 bolsas curso es un suplemento nutricional diseñado para ayudar a mantener las articulaciones sanas y flexibles. Este producto…
-
Potential Threat of Newly Identified ST20 Clone to Enzyme Inhibitor Combination Therapy: Findings from ESCMID Global 2024
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a significant challenge in nosocomial infections, with its resistance escalating, drawing global attention. At the 34th European Congress of Clinical Microbiology and Infectious Diseases (ESCMID Global 2024), a study by Professor Yunsong Yu’s team from the Zhejiang Provincial People’s Hospital presented the latest findings on the genomic epidemiology…
-
2024 CSCO Guidelines Conference | Prof. Dingwei Ye: Keeping Up with the Times, Serving Clinical Practice with a Prostate Cancer Guideline with Chinese Characteristics
Prostate cancer is the most common malignant tumor of the male urinary reproductive system. Compared to developed countries, China has a higher proportion of late-stage prostate cancer patients at diagnosis, resulting in poorer prognosis. In recent years, there have been rapid advancements in prostate cancer research. Therefore, developing diagnosis and treatment guidelines tailored to China…
-
2024 South-North Forum | Prof. Hong Hu: Should CDK4/6 Inhibitors Be Used for N0 Patients with Limited High-Risk Factors?
For hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer patients with no lymph node involvement (N0) and limited high-risk factors, the consensus has been that their risk of recurrence is low, and adjuvant endocrine therapy alone is sufficient. However, with the release of studies like NATALEE, it has become apparent that intensifying treatment…
Connecting Medical Expertise through Media